Validation of the Persian version of the sarcopenia-specific quality of life questionnaire (SarQoL®-IR)

Marzieh Mahmoodi; Najmeh Hejazi; Zahra Bagheri; Nasrin Nasimi; Cain C T Clark; Mahsa Moosavi; Mohammad Hossein Dabbaghmanesh; Zohreh Mazloom

doi:10.1007/s40520-022-02255-0

Validation of the Persian version of the sarcopenia-specific quality of life questionnaire (SarQoL®-IR)

Marzieh Mahmoodi, Najmeh Hejazi, Zahra Bagheri, Nasrin Nasimi, Cain C T Clark, Mahsa Moosavi, Mohammad Hossein Dabbaghmanesh, Zohreh Mazloom

Shiraz University of Medical Sciences

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

BACKGROUND: The sarcopenia quality of life (SarQoL) ® questionnaire is a specific tool to measure QoL in sarcopenia. The aim of this study was to validate the SarQoL ® questionnaire for evaluation of sarcopenia-related quality of life in Iranian community-dwelling older adults.

METHODS: Validity (discriminative power, construct validity), reliability (internal consistency, test-retest reliability), and floor/ceiling effects of SarQoL ® questionnaire were evaluated in the current study. Moreover, the SarQoL ® questionnaire was compared with the Short-Form 36-item (SF-36) and the EuroQoL 5-Dimensions (EQ-5D) questionnaires.

RESULTS: Among 501 community-dwelling older adults, 128 elderly participants (including 88 sarcopenic individuals) were recruited for validation. Participants with sarcopenia had lower quality of life than non-sarcopenic individuals (Total Score: 39.37 ± 7.45 vs. 65.09 ± 7.85, p < 0.001). Also, the findings demonstrated a high internal consistency (Cronbach's alpha of 0.881), excellent test-retest reliability (ICC = 0.995, 95% CI 0.990-0.998), and no floor/ceiling effect of SarQoL ® questionnaire.

CONCLUSION: This is the first study to confirm the reliability and validity of the Persian version of the SarQoL ® for the measurement of quality of life among Iranian sarcopenic older adults.

Original language	English
Pages (from-to)	137-145
Number of pages	9
Journal	Aging clinical and experimental research
Volume	35
Issue number	1
Early online date	26 Oct 2022
DOIs	https://doi.org/10.1007/s40520-022-02255-0
Publication status	E-pub ahead of print - 26 Oct 2022

Bibliographical note

Keywords

Persian
Quality of life
SarQoL
Sarcopenia
Validation

Access to Document

10.1007/s40520-022-02255-0

Cite this

@article{527ba142cb274c0abed891ace4b3a25a,

title = "Validation of the Persian version of the sarcopenia-specific quality of life questionnaire (SarQoL{\textregistered}-IR)",

abstract = "BACKGROUND: The sarcopenia quality of life (SarQoL) {\textregistered} questionnaire is a specific tool to measure QoL in sarcopenia. The aim of this study was to validate the SarQoL {\textregistered} questionnaire for evaluation of sarcopenia-related quality of life in Iranian community-dwelling older adults. METHODS: Validity (discriminative power, construct validity), reliability (internal consistency, test-retest reliability), and floor/ceiling effects of SarQoL {\textregistered} questionnaire were evaluated in the current study. Moreover, the SarQoL {\textregistered} questionnaire was compared with the Short-Form 36-item (SF-36) and the EuroQoL 5-Dimensions (EQ-5D) questionnaires. RESULTS: Among 501 community-dwelling older adults, 128 elderly participants (including 88 sarcopenic individuals) were recruited for validation. Participants with sarcopenia had lower quality of life than non-sarcopenic individuals (Total Score: 39.37 ± 7.45 vs. 65.09 ± 7.85, p < 0.001). Also, the findings demonstrated a high internal consistency (Cronbach's alpha of 0.881), excellent test-retest reliability (ICC = 0.995, 95% CI 0.990-0.998), and no floor/ceiling effect of SarQoL {\textregistered} questionnaire. CONCLUSION: This is the first study to confirm the reliability and validity of the Persian version of the SarQoL {\textregistered} for the measurement of quality of life among Iranian sarcopenic older adults. ",

keywords = "Persian, Quality of life, SarQoL, Sarcopenia, Validation",

author = "Marzieh Mahmoodi and Najmeh Hejazi and Zahra Bagheri and Nasrin Nasimi and Clark, {Cain C T} and Mahsa Moosavi and Dabbaghmanesh, {Mohammad Hossein} and Zohreh Mazloom",

note = "{\textcopyright} 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.",

year = "2022",

month = oct,

day = "26",

doi = "10.1007/s40520-022-02255-0",

language = "English",

volume = "35",

pages = "137--145",

journal = "Aging clinical and experimental research",

issn = "1594-0667",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Validation of the Persian version of the sarcopenia-specific quality of life questionnaire (SarQoL®-IR)

AU - Mahmoodi, Marzieh

AU - Hejazi, Najmeh

AU - Bagheri, Zahra

AU - Nasimi, Nasrin

AU - Clark, Cain C T

AU - Moosavi, Mahsa

AU - Dabbaghmanesh, Mohammad Hossein

AU - Mazloom, Zohreh

PY - 2022/10/26

Y1 - 2022/10/26

N2 - BACKGROUND: The sarcopenia quality of life (SarQoL) ® questionnaire is a specific tool to measure QoL in sarcopenia. The aim of this study was to validate the SarQoL ® questionnaire for evaluation of sarcopenia-related quality of life in Iranian community-dwelling older adults. METHODS: Validity (discriminative power, construct validity), reliability (internal consistency, test-retest reliability), and floor/ceiling effects of SarQoL ® questionnaire were evaluated in the current study. Moreover, the SarQoL ® questionnaire was compared with the Short-Form 36-item (SF-36) and the EuroQoL 5-Dimensions (EQ-5D) questionnaires. RESULTS: Among 501 community-dwelling older adults, 128 elderly participants (including 88 sarcopenic individuals) were recruited for validation. Participants with sarcopenia had lower quality of life than non-sarcopenic individuals (Total Score: 39.37 ± 7.45 vs. 65.09 ± 7.85, p < 0.001). Also, the findings demonstrated a high internal consistency (Cronbach's alpha of 0.881), excellent test-retest reliability (ICC = 0.995, 95% CI 0.990-0.998), and no floor/ceiling effect of SarQoL ® questionnaire. CONCLUSION: This is the first study to confirm the reliability and validity of the Persian version of the SarQoL ® for the measurement of quality of life among Iranian sarcopenic older adults.

AB - BACKGROUND: The sarcopenia quality of life (SarQoL) ® questionnaire is a specific tool to measure QoL in sarcopenia. The aim of this study was to validate the SarQoL ® questionnaire for evaluation of sarcopenia-related quality of life in Iranian community-dwelling older adults. METHODS: Validity (discriminative power, construct validity), reliability (internal consistency, test-retest reliability), and floor/ceiling effects of SarQoL ® questionnaire were evaluated in the current study. Moreover, the SarQoL ® questionnaire was compared with the Short-Form 36-item (SF-36) and the EuroQoL 5-Dimensions (EQ-5D) questionnaires. RESULTS: Among 501 community-dwelling older adults, 128 elderly participants (including 88 sarcopenic individuals) were recruited for validation. Participants with sarcopenia had lower quality of life than non-sarcopenic individuals (Total Score: 39.37 ± 7.45 vs. 65.09 ± 7.85, p < 0.001). Also, the findings demonstrated a high internal consistency (Cronbach's alpha of 0.881), excellent test-retest reliability (ICC = 0.995, 95% CI 0.990-0.998), and no floor/ceiling effect of SarQoL ® questionnaire. CONCLUSION: This is the first study to confirm the reliability and validity of the Persian version of the SarQoL ® for the measurement of quality of life among Iranian sarcopenic older adults.

KW - Persian

KW - Quality of life

KW - SarQoL

KW - Sarcopenia

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=85140581740&partnerID=8YFLogxK

U2 - 10.1007/s40520-022-02255-0

DO - 10.1007/s40520-022-02255-0

M3 - Article

C2 - 36289155

SN - 1594-0667

VL - 35

SP - 137

EP - 145

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

IS - 1

ER -

Validation of the Persian version of the sarcopenia-specific quality of life questionnaire (SarQoL®-IR)

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this